Cefepime Dosing for GFR 33 mL/min
For a patient with GFR 33 mL/min, reduce the cefepime dose to 1 g every 24 hours or 500 mg every 12 hours, depending on infection severity, as dose adjustment is mandatory to prevent life-threatening neurotoxicity. 1
Critical Safety Consideration
The FDA label explicitly states that dose adjustment is required for creatinine clearance ≤60 mL/min to compensate for slower renal elimination 1. This is not optional—serious adverse events including life-threatening or fatal encephalopathy, myoclonus, and seizures have occurred in patients with renal impairment given unadjusted doses 1.
Dosing Algorithm Based on Renal Function
With a GFR of 33 mL/min, your patient falls into the moderate-to-severe renal impairment category:
- For moderate infections: 500 mg every 12 hours
- For severe infections or resistant organisms: 1 g every 24 hours (or 500 mg every 12 hours)
- Maximum recommended: Do not exceed 2 g total daily dose at this level of renal function
The pharmacokinetic data demonstrates that cefepime half-life increases from 2.3 hours in normal renal function to approximately 6-8 hours when GFR is 30-50 mL/min 2, 3. Total clearance decreases proportionally with declining GFR, with a linear relationship (clearance = 0.92 × GFR - 2.0) 3.
Neurotoxicity Risk at This GFR Level
Cefepime has a relative pro-convulsive activity 160 times that of penicillin G 4, making it one of the highest-risk beta-lactams for CNS toxicity. Research shows:
- No neurotoxicity occurs below trough concentrations of 7.7 mg/L
- Concentrations ≥38.1 mg/L always cause neurological side effects
- Patients with renal insufficiency (like yours with GFR 33) had significantly higher neurotoxicity rates (35.1% mortality in those with neurotoxicity vs 7.8% without) 5
At GFR 33 mL/min without dose adjustment, your patient will accumulate toxic levels rapidly.
Monitoring Recommendations
For this patient:
- Consider therapeutic drug monitoring (TDM) targeting trough concentrations <7.5 mg/L to avoid neurotoxicity 5
- Monitor for early signs of neurotoxicity: confusion, hallucinations, myoclonus, seizures 1
- Recheck renal function every 48-72 hours during therapy, as critically ill patients may have fluctuating kidney function
Extended Infusion Consideration
If treating a resistant organism (MIC ≥2-4 mg/L), consider:
- Administering the reduced dose as a 3-hour extended infusion rather than 30-minute infusion
- This improves pharmacodynamic target attainment (time above MIC) without increasing total daily dose and neurotoxicity risk 4, 6
Common Pitfall to Avoid
Do not use standard dosing (2 g every 8-12 hours) at this GFR level. The most dangerous error is failing to adjust for renal function, which leads to drug accumulation and potentially fatal neurotoxicity. The evidence is unequivocal that cefepime dosing must be reduced proportionally to declining creatinine clearance 1, 2, 3.